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Abstract 
This study was carried out to evaluate the antibacterial, antifungal and cytotoxic effects of chloroform, ethyl acetate and 
aqueous fractions obtained from a methanol 80 % extract of Cestrum nocturnum L. (family Solanaceae) aerial parts, and to 
investigate the bioactive constituents present in these fractions. The results showed that the chloroform fraction had the 
highest antibacterial effect and cytotoxicity against lung, colon and hepatocellular carcinoma cell lines, while the ethyl 
acetate fraction displayed the highest antifungal activity and cytotoxicity against cervical carcinoma cell lines. 
Phytochemical analysis showed the presence of triterpenes, coumarins and flavonoids in the chloroform fraction. Flavonoids, 
triterpenes and carbohydrates in the ethyl acetate fraction while tannins, flavonoids, saponins, carbohydrates and triterpenes 
were detected in the aqueous fraction. β-sitosterol, stigmasterol, protocatechuic acid and apigenin were isolated from the 
chloroform fraction; Kaempferol 8-O-methyl ether, kaempferol, kaempferol 3-O-α-rhamnoside and luteolin 7-O-β-glucoside 
were isolated from the ethyl acetate fraction, while kaempferol di-sugars: kaempferol 3-O-β-glucoside-7-O-α-rhamnoside 
and kaempferol 3,7-di-O-α-rhamnoside, were isolated from the aqueous fraction. This study proves the bioactivities of C. 
nocturnum aerial parts that can be explored as a source of medicinal compounds. 
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* Corresponding author. e-mail: khalednabih2015@yahoo.co.uk. 
1. Introduction 
There is an urgent need to discover new antimicrobial 
and antitumor agents following the discovery of many 
infectious diseases (Hawkey, 2008; Jemal et al., 2011). 
Phytochemical screening of various plants revealed that 
secondary metabolites might be bioactive compounds with 
different properties such as antibacterial, antifungal, 
antioxidant, antidiabetic and anticancer (Gurib-Fakim, 
2006; Phillipson, 2007; Alonso-Castro et al., 2011). 
Therefore, compounds or extracts from the plant origin 
should be explored for the development of new 
formulations against different diseases.  
Cestrum nocturnum L. is an evergreen shrub from the 
family Solanaceae that grows in tropical and sub-tropical 
regions throughout the world (Roig, 1988). Leaves of C. 
nocturnum were used to treat burns and swellings (Perez-
Saad and Buznego, 2008). The volatile oil was used to 
prevent malaria (Mimaki et al., 2006). Leaves had 
significant analgesic and bactericidal effects (Huang et al., 
2006). The inhibitory effects on the central nerve system 
and cardiac arrhythmic effect of this plant are also 
documented (Zeng et al., 2002). Polysaccharides extracts 
of C. nocturnum had antitumor effects (Zhong et al., 
2008). Also the whole plant showed an antimicrobial 
activity against pathogenic microorganisms (Khan et al., 
2011). The essential oil from the plant showed an 
inhibition of some plant pathogens (Al-Reza et al., 2009a), 
and inhibitory effects on food-borne pathogens (Al-Reza et 
al., 2009b).  Its chloroform and toluene extracts gave 
behavior and analgesic effects (Rodriguez et al., 2005). 
Moreover, C. nocturnum leaves had calcinogenic 
glycoside (Mello, 2003), nocturnoside A and nocturnoside 
B (Ahmad et al., 1995), phenol glucosides (Sahai et al., 
1994), flavonol glycosides and steroidal saponins (Mimaki 
et al., 2001; Mimaki et al., 2002) and also some recent 
studies have been done on the plant (Doshi and Mukadam 
2016, Chaskar et al. 2017). In the present study, the 
antibacterial, antifungal and cytotoxic activities of 
different fractions obtained from C. nocturnum aerial parts 
were evaluated. Furthermore, a phytochemical characteri-
zation of each fraction was carried out in order to 
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understand the compounds involved in each individual 
fraction bioactivity. 
2. Material and Methods 
2.1. Equipments, Materials and Chemicals 
UV/VIS: Shimadzu UV-visible recording spectrophoto-
meter model-UV 240 (NRC, Egypt). Spectroscopic data 
(1H-NMR, 13C-NMR): Varian Unity Inova. MS (Finnigan 
MAT SSQ 7000, 70 ev). Silica gel (60-200 mesh, Merck) 
for column chromatography, Thin Layer Chromatography 
(TLC): pre-coated sheets of silica gel 60 F254 (Merck). 
Polyamide powder of caprolactam type (MN-polyamide 
SC6, Macherey Nagel, Pharmacia Fine Chemicals) for 
column chromatography, Paper Chromatography (PC), 
Whatman No.1 (Whatman Led. Maid Stone, Kent, 
England) sheets. Sephadex LH-20 (Sigma). Solvent 
mixtures, BAW (n-butanol: acetic acid: water 4:1:5 upper 
phase, 15% acetic acid: water: glacial acetic acid: 85:15).  
2.2. Plant Material  
Cestrum nocturnum aerial parts were collected from the 
Agricultural Research Centre, Giza, Egypt in May 2011 
during flowering and identified by Dr. Mohammed El-
Gebaly, Department of Botany, National Research Centre 
(NRC) and by Mrs. Tereez Labib, Consultant of Plant 
Taxonomy at the Ministry of Agriculture and director of 
Orman botanical garden, Giza, Egypt. A voucher specimen 
is deposited in the herbarium of Agricultural Research 
Centre, Giza, Egypt. 
2.3. Preparation of the Plant Extracts   
Air-dried powder from the aerial parts of C. nocturnum 
(680 g) was extracted with methanol 80 % several times at 
room temperature. The extract was concentrated to dryness 
by rotary evaporator giving 35 g of the crude extract. The 
extract was fractionated with chloroform, ethyl acetate 
solvents. The solvent of each partition was evaporated to 
dryness using rotary evaporator resulting in products 
weighing 9.5 g, 7 g and 16.5 g. of chloroform, ethyl 
acetate and water extraction, respectively. Each fraction 
was tested for the presence of bioactive compounds by 
using the following standard tests: Molisch test for 
carbohydrates, Shinoda test for flavonoids, Forth test for 
saponins, Salkowski for terpenes and sterols, FeCl3 and 
Mayer's reagents for the detection of tannins and alkaloids, 
respectively (Harborne, 1973; Trease and Evans, 1989; 
Sofowra, 1993). 
2.4. Antibacterial Activity 
The following Gram (-) (Enterobacter cloacae human 
isolate, Escherichia coli ATCC 35210, Pseudomonas 
aeruginosa ATCC 27853 and Salmonella typhimurium 
ATCC 13311) as well as Gram (+) bacteria (Bacillus 
cereus clinical isolate, Listeria monocytogenes NCTC 
7973, Micrococcus flavus ATCC 10240 and 
Staphylococcus aureus ATCC 6538) were used. These 
bacteria were obtained from Mycological Laboratory, 
Department of Plant Physiology, Institute for Biological 
Research ''Siniša Stanković'', University of Belgrade, 
Serbia. The antibacterial assay was carried out by 
microdilution method (Hanel and Raether, 1988; Espinel-
Ingroff, 2001). The bacterial suspensions were adjusted 
with sterile saline to a concentration of 1.0×105 CFU/mL. 
The inocula were prepared daily and stored at 4°C until 
use. Dilutions of the inocula were cultured on solid 
medium to verify the absence of contamination and to 
check the validity of the inoculum. The minimum 
inhibitory and bactericidal concentrations (MICs and 
MBCs) were determined using 96-well microtiter plates. 
The bacterial suspension was adjusted with sterile saline to 
a concentration of 1.0×105 CFU/mL. The fractions of the 
same samples (three samples repeated three times) and 
three extract samples were collected for testing (1 and 10 
mg/mL) in broth.  
Tryptic Soy Broth (TSB) medium (100 μL) with 
bacterial inoculum (1.0×104 CFU per well) to achieve the 
wanted concentrations. The microplates were incubated on 
rotary shaker (160 rpm) for twenty-four hours at 37°C. The 
following day, 30 μL of 0.2 mg/mL solution of INT (p-
iodonitrotetrazolium violet) were added, and the plates 
were returned to the incubator for at least one-half hour to 
ensure an adequate color reaction. Inhibition of growth 
was indicated by a clear solution or a definite decrease in 
color reaction. The lowest concentrations without visible 
growth (under the binocular microscope) were defined as 
concentrations that completely inhibited bacterial growth 
(MICs). The MBCs were determined by serial sub-
cultivation of 2 μL into microtiter plates containing 100 μL 
of broth per well and further incubation for twenty-four 
hours. The lowest concentration with no visible growth 
was defined as the MBC, indicating 99.5 % killing of the 
original inoculum. The optical density of each well was 
measured at a wavelength of 655 nm by microplate 
manager 4.0 (Bio-Rad Laboratories), and was compared 
with a blank and the positive control. The antibiotics 
streptomycin and ampicillin were used as positive controls 
(1 mg/mL in sterile physiological saline). Three 
independent experiments were performed in triplicate. 
2.5. Antifungal Activity 
The used fungi; Aspergillus fumigatus (ATCC 1022), 
Aspergillus versicolor (ATCC 11730), Aspergillus 
ochraceus (ATCC 12066), Aspergillus niger (ATCC 
6275), Trichoderma viride (IAM 5061), Penicillium 
funiculosum (ATCC 36839), Penicillium ochrochloron 
(ATCC 9112) and Penicillium verrucosum var. cyclopium 
were obtained from Mycology Laboratory, Department of 
Plant Physiology, Institute for Biological Research ''Siniša 
Stanković'', University of Belgrade, Serbia. The 
Micromycetes were maintained on malt agar and the 
cultures were stored at 4° C and sub-cultured once a 
month. The antifungal assay was carried out by a modified 
microdilution technique (Hanel and Raether, 1988; 
Espinel-Ingroff, 2001). The fungal spores were washed 
from the surface of agar plates with sterile 0.85 % saline 
containing 0.1 % Tween 80 (v/v). The spore suspension 
was adjusted with sterile saline to a concentration of 
approximately 1.0×105 in a final volume of 100 μL per 
well. The inocula were stored at 4° C for further use. 
Dilutions of the inoculum were cultured on solid malt agar 
to verify the absence of contamination and to check the 
validity of the inoculum. MIC determinations were 
performed by a serial dilution technique using 96-well 
microtiter plates. The examined fractions of the same 
sample (repeated three times) were diluted in 5 % of 
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DMSO (1 mg/mL and 10 mg/mL) and added in broth malt 
medium (MA) with inoculum. The microplates were 
incubated in a rotary shaker (160 rpm) for seventy-two 
hours at 28° C. The lowest concentrations without visible 
growth (at the binocular microscope) were defined as 
MICs. The fungicidal concentrations (MFCs) were 
determined by serial subcultivation of 2 μL of tested 
fractions dissolved in medium and inoculated for seventy-
two hours, into microtiter plates containing 100 μL of 
broth per well and further incubation for seventy-two 
hours at 28° C. The lowest concentration with no visible 
growth was defined as MFC indicating 99.5 % killing of 
the original inoculum. The fungicides bifonazole and 
ketoconazole were used as positive controls (1-3500 
μg/mL). Three independent experiments were performed 
in duplicate.                                                         
2.6. Cytotoxicity in Human Tumor Cell Lines and in Liver 
Primary Cell Culture 
Five human tumor cell lines were used: MCF-7 (breast 
adenocarcinoma), NCI-H460 (non-small cell lung cancer), 
HCT-15 (colon carcinoma), HeLa (cervical carcinoma) 
and HepG2 (hepatocellular carcinoma). Cells were 
routinely maintained as adherent cell cultures in RPMI-
1640 medium containing 10 % heat-inactivated fetal 
bovine serum (FBS) and 2 mM glutamine (MCF-7, NCI-
H460 and HCT-15) or in DMEM supplemented with 10 % 
FBS, 2 mM glutamine, 100 U/mL penicillin and 100 
mg/mL streptomycin (HeLa and HepG2 cells), at 37 ºC, in 
a humidified air incubator containing 5 % CO2. Each cell 
line was plated at an appropriate density (7.5 × 103 
cells/well for MCF-7, NCI-H460 and HCT-15 or 1.0 × 104 
cells/well for HeLa and HepG2) in 96-well plates. 
Sulforhodamine B assay was performed according to a 
procedure previously described by Guimarães et al., 
(2013).                          
For the hepatotoxicity evaluation, a cell culture was 
prepared from a freshly-harvested porcine liver obtained 
from a local slaughter house, according to a procedure 
established by Guimarães et al. (2013); it was designed as 
PLP2. Cultivation of the cells was continued with direct 
monitoring every two to three days using a phase contrast 
microscope. Before confluence was reached, cells were 
subcultured and plated in 96-well plates at a density of 
1.0×104 cells/well, and cultivated in DMEM medium with 
10 % FBS, 100 U/mL penicillin and 100 µg/mL 
streptomycin. Three independent experiments were 
performed in triplicate, and the results were expressed as 
mean values ± standard deviation (SD).                                                                                                          
2.7. Phytochemical Characterization of C. nocturnum 
Fractions 
2.7.1. Phytochemical Analysis of Chloroform Fraction 
 It was subjected to silica gel column chromatography 
using chloroform (CHCl3) as eluent and a gradually 
increasing amount of methanol (MeOH). Four compounds 
were isolated.  Compound one (see figure 3) isolated from 
CHCl3:MeOH (98:2) elution, and compound two was 
isolated through elution with CHCl3:MeOH (96:4). 
Compound three was isolated through elution with CHCl3: 
MeOH (90:10), and then compound four was isolated 
through elution with CHCl3: MeOH (85:15). 
2.7.2. Phytochemical Analysis of Ethyl Acetate Fraction 
 It was subjected to silica gel column chromatography 
using CHCl3 as eluent and a gradually increasing amount 
of ethyl acetate (EtOAc) and MeOH. Compound five was 
isolated from CHCl3: EtOAc (50:50) elution, compound 
six was isolated from EtOAc elution and compounds seven 
and eight were isolated through further elution with EtOAc 
and MeOH, gradually. 
2.7.3. Phytochemical Analysis of Aqueous Fraction 
 It was subjected to polyamide column chromatography 
using distilled water and gradually increasing amounts of 
MeOH. Compounds nine and ten were isolated through 
this elution. All the compounds were purified on sephadex 
LH–20 column which was eluted with mixtures of 
methanol with distilled water. 
2.7.4. Acid Hydrolysis of Flavonoid Glycosides  
Solutions of 5 mg of compounds 7, 8, 9 and 10 in 5 ml 
10% HCl were heated for five hours. The aglycones were 
extracted with EtOAc and identified by co-TLC with 
authentic standards. The sugars in the aqueous layer was 
identified by co-paper chromatography (co-PC) with 
authentic markers on Whatman No. 1 sheets in solvent 
system (n-BuOH-AcOH-H2O 4:1:5 upper layer). 
3. Results and Discussion 
The obtained results for the antibacterial and antifungal 
activity are presented in Tables 1 and 2, Figures 1 and 2, 
respectively. The chloroform fraction showed activity 
against all the tested bacteria (MIC 0.6-2.5 mg/mL and 
MBC 1.25-5.0 mg/mL); ethyl acetate fraction exhibited 
MICs of 1.25-3.75 mg/mL and MBCs of 2.5-7.5 mg/mL, 
and the aqueous fraction revealed MICs of 0.6-1.25 
mg/mL and MBCs of 1.25-5.0 mg/mL. It can be observed 
that the chloroform fraction gave the highest antibacterial 
activity, except for L. monocytogenes and E. cloacae, 
where the aqueous fraction showed a higher effect. The 
least effective was the ethyl acetate fraction. The most 
sensitive bacteria were E. cloacae, while the most resistant 
one was P. aeruginosa, followed by L. monocytogenes. 
 All the fractions were more active against microfungi 
(Table 2 and Figure 2). The chloroform fraction inhibited 
all microfungi at 0.15-0.6 mg/mL and completely stopped 
the growth at 0.3-1.25 mg/mL. The ethyl acetate fraction 
showed inhibitory concentrations at 0.075-0.3 mg/mL and 
fungicidal effects at 0.15-0.6 mg/mL. The aqueous extract 
showed MICs of 0.15-2.5 mg/mL and MFCs at 0.60-5.0 
mg/mL. The highest activity was observed for the ethyl 
acetate fraction, while the aqueous fraction showed the 
lowest antifungal effect.  The most sensitive microfungi 
was P. ochrochloron, on the other hand, A. fumigatus was 
the most resistant to the tested fractions. The ethyl acetate 
fraction showed higher antifungal effect towards P. 
ochrochloron than both mycotics. All the tested fractions 
exhibited higher antifungal activity against P. funiculosum 
than ketoconazole. Chloroform and ethyl acetate fractions 
possessed higher effect on P. verrucosum var. cyclopium 
than ketoconazole. The Chloroform extract showed the 
same MIC but higher MFC for A. niger and P. 
ochrochloron than ketoconazole. In general, bacteria are 
more resistant than fungi (Soković et al., 2010). The 
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observed antibacterial activity from the chloroform 
fraction can be attributed to the presence of compounds; 
stigmasterol isolated from that fraction has a moderate 
antibacterial effect when compared to the reference drug 
(ciprofloxacin). This confirmed the antibacterial activity of 
stigmasterol against Acetobacter sp., E. coli, S. aureus, 
Streptococcus sp., and P. aeruginosa (Sileshi et al., 2012); 
β-sitosterol also has a moderate antibacterial effect (Sileshi 
et al., 2012). Apigenin has a good antibacterial effect 
against several bacterial strains and the values are close to 
the antibacterial property of broad-spectrum, antibiotic 
tetracycline (Rui et al., 2013). Also, only chloroform 
fraction possessed coumarins which can have influence in 
its higher antibacterial effect. It has been reported that 
some groups in coumarins skeleton result in increasing 
lipophilicity of the molecule (Stavri and Gibbons, 2005). 
Table 1. Antibacterial activity of different fractions of Cestrum nocturnum aerial parts. 
* Minimum inhibitory concentration - MIC; Minimum bactericidal concentration - MBC. 
Table 2. Antifungal activity of different fractions of Cestrum nocturnum aerial parts. 
* Minimum inhibitory concentration - MIC; Minimum fungicidal concentration - MFC. 
Bacteria 
Chloroform 
MIC (mg/mL)* 
MBC (mg/mL) 
Ethyl acetate 
MIC (mg/mL) 
MBC (mg/mL) 
Aqueous 
MIC (mg/mL) 
MBC (mg/mL) 
Streptomycin 
MIC (mg/mL) 
MBC (mg/mL) 
Ampicillin 
MIC (mg/mL) 
MBC (mg/mL) 
Bacillus  
cereus 
0.6±0.06 
1.25±0.10 
1.25±0.10 
5.0±0.00 
1.25±0.00 
2.5±0.30 
0.05±0.005 
0.1±0.03 
0.1±0.05 
0.15±0.05 
Micrococcus  flavus 
0.6±0.00 
2.5±0.30 
1.25±0.10 
5.0±0.60 
1.25±0.00 
2.5±0.00 
0.125±0.015 
0.25±0.003 
0.1±0.00 
0.15±0.06 
Staphylococcus 
aureus 
0.6±0.06 
2.5±0.00 
2.5±0.30 
5.0±0.30 
1.25±0.10 
2.5±0.30 
0.25±0.003 
0.50±0.00 
0.1±0.05 
0.15±0.00 
14TListeria 
monocytogenes14T 
2.5±0.30 
5.0±0.60 
2.5±0.00 
5.0±0.00 
1.25±0.10 
5.0±0.60 
0.15±0.05 
0.30±0.03 
0.15±0.03 
0.30±0.01 
Escherichia coli 
0.6±0.00 
2.5±0.30 
1.25±0.10 
2.5±0.30 
1.25±0.10 
2.5±0.30 
0.10±0.03 
0.50±0.06 
0.30±0.05 
0.50±0.06 
Pseudomonas 
aeruginosa 
1.25±0.10 
2.5±0.30 
3.75±0.10 
7.5±0.00 
1.25±0.00 
2.5±0.30 
0.05±0.006 
0.10±0.0 
0.10±0.00 
0.20±0.05 
Enterobacter 
cloacae 
0.6±0.06 
2.5±0.30 
1.25±0.10 
5.0±0.60 
0.6±0.60 
1.25±0.00 
0.05±0.005 
0.10±0.06 
0.15±0.00 
0.20±0.06 
Salmonella 
typhimurium 
1.25±0.00 
2.5±0.30 
1.25±0.00 
5.0±0.30 
1.25±0.00 
2.5±0.30 
0.05±0.006 
0.10±0.03 
0.15±0.03 
0.20±0.00 
Fungi 
Chloroform 
MIC (mg/mL)* 
MBC (mg/mL) 
Ethyl acetate 
MIC (mg/mL) 
MBC (mg/mL) 
Aqueous 
MIC (mg/mL) 
MBC (mg/mL) 
Bifonazole 
MIC (mg/mL) 
MBC (mg/mL) 
Ketoconazole 
MIC (mg/mL) 
MBC (mg/mL) 
Aspergillus 
fumigatus 
0.6±0.06 
1.25±0.10 
0.3±0.00 
0.6±0.06 
2.5±0.00 
5.0±0.60 
0.15±0.03 
0.20±0.06 
0.20±0.03 
0.50±0.05 
Aspergillus 
versicolor 
0.6±0.00 
1.25±0.00 
0.3±0.06 
0.6±0.00 
0.6±0.06 
2.5±0.30 
0.10±0.05 
0.20±0.03 
0.20±0.03 
0.50±0.05 
Aspergillus 
ochraceus 
0.3±0.06 
0.6±0.06 
0.3±0.06 
0.6±0.00 
0.6±0.06 
1.25±0.00 
0.15±0.03 
0.20±0.06 
0.15±0.03 
0.20±0.06 
Aspergillus 
niger 
0.2±0.03 
0.3±0.00 
0.2±0.03 
0.6±0.06 
0.6±0.06 
1.25±0.10 
0.15±0.03 
0.20±0.03 
0.20±0.06 
0.50±0.05 
Penicillium 
verrucosum 
0.2±0.03 
0.3±0.03 
0.2±0.03 
0.6±0.06 
0.6±0.06 
1.25±0.00 
0.15±0.05 
0.20±0.03 
1.0±0.30 
1.0±0.30 
Penicillium 
ochrochloron 
0.15±0.03 
0.3±0.06 
0.075±0.00 
0.15±0.03 
0.15±0.03 
0.6±0.06 
0.20±0.06 
0.25±0.05 
0.20±0.03 
0.50±0.06 
Penicillium 
funiculosum 
0.3±0.00 
0.6±0.00 
0.3±0.06 
0.6±0.00 
0.15±0.00 
0.6±0.06 
0.20±0.03 
0.25±0.05 
2.5±0.30 
3.5±0.50 
Trichoderma 
viride 
0.6±0.06 
1.25±0.00 
0.3±0.06 
0.6±0.00 
0.15±0.00 
0.6±0.06 
0.10±0.05 
0.20±0.06 
0.20±0.03 
0.30±0.06 
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Figure 1. Antibacterial activity of the chloroform extract of 
Cestrum nocturnum aerial parts by microdilution method. 
Antibacterial effect of extract at different concentrations 0.6-2.5 
mg/mL (MIC and MBC). Comparison between control-bacterial 
growth (K-red color) and treated samples (yellow color MIC and 
MBC) and treated samples with no activity (red color) in INT 
assay. 
Figure 2. Antifungal activity of the chloroform extract of Cestrum 
nocturnum aerial parts by microdilution method. Control (K-
fungal growth) and treated samples (MIC and MFC, 0.2-1.25 
mg/mL–clean, transparent wells with no fungal growth, rows 1-3) 
and treated samples with fungal growth and no activity, rows 4-
10. 
Kaempferol isolated from ethyl acetate fraction showed 
a significant antimicrobial activity against all the tested 
organisms with MIC values between 16 and 63 μg/mL 
(Teffo et al., 2010). Kaempferol di-sugars isolated from 
aqueous fraction showed a good antimicrobial activity 
against most of the studied microorganisms (Salwa et al., 
2012).   
The three fractions revealed cytotoxicity against 
different human tumor cell lines (Table 3). Nevertheless, 
the chloroform fraction proved to be more active against 
NCI-H460 (lung carcinoma; GI50 70.54 µg/mL), HCT-15 
(colon carcinoma; GI50 86.65 µg/mL) and HepG2 
(hepatocellular carcinoma, GI50 171.83 µg/mL) cell lines, 
while the ethyl acetate and the aqueous fractions were 
more efficient against HeLa (cervical carcinoma, GI50 
57.48 µg/mL) and MCF-7 (breast carcinoma, GI50 55.28 
µg/mL) cell lines, respectively. The ethyl acetate fraction 
(up to 400 µg/mL) was not toxic to non tumor liver cells; 
the other two fractions showed some hepatotoxicity, but at 
higher concentrations than the ones allowing anti-tumor 
effects. Ellipticine, a positive control, was used as a 
standard for comparison with the studied fractions. 
The Cytotoxic activity observed for the chloroform 
fraction can be attributed to the presence of apigenin 
which showed a significant cytotoxic effect against 
different tumor cell lines (Rui et al., 2013). The observed 
cytotoxic activity of ethyl acetate fraction can be attributed 
to the presence of the main flavonoid constituent, luteolin 
7-O-glucoside which showed significant cytotoxicity 
(LDR50R = 85 ±34 μg/mL) (Rilka et al., 2003), while the 
observed cytotoxicity of the aqueous fraction can be 
attributed to the presence of kaempferol di-sugars. Many 
reports showed that kaempferol glycosides cause cell death 
in a variety of cancer cells (Brusselmans et al., 2005, 
Tomczyk et al., 2008). 
The results of phytochemical analysis of the fractions 
of C. nocturnum aerial parts from the methanol 80 % 
extract are included in Table 4. Triterpenes, coumarins and 
flavonoids were detected in the chloroform fraction. 
Flavonoids, triterpenes and carbohydrates were detected in 
the ethyl acetate fraction, while tannins, flavonoids, 
saponins, carbohydrates and triterpenes were detected in 
the aqueous fraction. Isolation and purification of 
chloroform, ethyl acetate and aqueous fractions allowed 
the identification of ten bioactive compounds: β-sitosterol, 
stigmasterol,  protocatechuic acid and apigenin from 
chloroform fraction; kaempferol 8-O-methyl ether, 
kaempferol, kaempferol 3-O-α-rhamnoside and luteolin 7-
O-β-glucoside from ethyl acetate fraction; and kaempferol-
disugars, kaempferol 3-O-β-glucoside-7-O-α-rhamnoside 
and kaempferol 3,7-di-O-α-rhamnoside from aqueous 
fraction (Figure 3). The chemical structures were 
determined by UV, P1PH-NMR, P13PC-NMR, and MS analyses. 
Table 3. Cytotoxicity of different fractions of Cestrum nocturnum 
aerial parts in human tumor cell lines and in non-tumor liver 
primary culture. 
 
Chloroform 
(GIR50R,  
µg/mL)* 
Ethyl acetate 
(GIR50R, 
 µg/mL) 
Aqueous 
(GIR50R, 
 µg/mL) 
Ellipticine 
(GIR50R, 
µg/mL) 
HCT-15 (colon 
carcinoma) 
86.65±5.86 223.00±4.03 98.11±8.48 1.91±0.06 
HepG2 
(hepatocellular 
carcinoma) 
171.83±11.85 213.18±9,50 225.86±16.92 3.22±0.67 
HeLa (cervical 
carcinoma) 
62.49±4.36 57.48±5.37 61.34±3.59 1.14±0.21 
MCF-7 (breast 
carcinoma) 
66.22±5.70 194.22±5.73 55.28±4.87 0.91±0.04 
NCI-H460 (lung 
carcinoma) 
70.54±6.56 185.27±5.18 83.41±0.91 1.42±0.00 
PLP2 (non-
tumour liver 
cells) 
323.44±9.67 >400 285.44±6.03 2.06±0.03 
* GIR50R values correspond to the sample concentration achieving 
50% of growth inhibition in human tumour cell lines or in liver 
primary culture PLP2.
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 Table 4. Phytochemical analysis of different fractions of Cestrum 
nocturnum aerial parts. 
* (-) denotes the absence of the constituents; (+) denotes the 
presence of the constituents.   
Figure 3. Chemical structure of the compounds isolated and 
identified in chloroform (1. β-sitosterol, 2. stigmasterol, 3. 
protocatechuic acid, 4. apigenin), ethyl acetate (5. kaempferol 8-
O-methyl ether, 6. kaempferol, 7. kaempferol 3-O-α-rhamnoside, 
8. luteolin 7-O-β-glucoside) and aqueous (9. kaempferol 3-O-β-
glucoside-7-O-α-rhamnoside, 10. kaempferol 3,7-di-O-α-
rhamnoside) fractions.   
4. Conclusions 
The present results proved that the chloroformR Rfraction 
possessed the highest antibacterial activity due to the 
presence of coumarins and the presence of β-sitosterol, 
stigmasterol, protocatechuic acid and apigenin which 
could also contribute to the highest antibacterial activity of 
that fraction, and to the highest cytotoxicity against lung, 
colon and hepatocellular carcinoma cell lines. On the other 
hand, compounds such as kaempferol 8-O-methyl ether, 
kaempferol, kaempferol 3-O-α-rhamnoside and luteolin 7-
O-β-glucoside could be related to the highest antifungal 
activity and cytotoxicity against cervical carcinoma cell 
line, displayed by the ethyl acetate fraction. Nevertheless, 
the different bioactivities exhibited by the fractions can 
also be due to the synergistic effect of different 
compounds present in the fractions or by the presence of 
other compounds that may be active even in small 
concentrations. The results obtained herein support the 
traditional medicinal use of Cestrum nocturnum, and 
provide grounds for further establishment of its use. 
Further studies are required to develop strategies for 
practical application.  
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